Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Marita Sporstøl Fønhus"'
Autor:
Katherine Whitehouse, Ashley Brant, Marita Sporstol Fonhus, Antonella Lavelanet, Bela Ganatra
Publikováno v:
Contraception: X, Vol 2, Iss , Pp 100037- (2020)
Background: Mifepristone and misoprostol are recommended for second-trimester medical abortion, but consensus is unclear on the ideal regimen. Objectives: The objectives were to systematically review randomized controlled trials (RCTs) investigating
Externí odkaz:
https://doaj.org/article/d44bb4635d8a49dcab048250ae7eb4d6
Autor:
Claire Glenton, Nicholas Henschke, John Eyers, Lavanya Vasudevan, Tigest Tamrat, Nicola Maayan, Simon Lewin, Marita Sporstøl Fønhus, Garrett Mehl
Publikováno v:
The Cochrane Database of Systematic Reviews
Background Ministries of health, donors, and other decision‐makers are exploring how they can use mobile technologies to acquire accurate and timely statistics on births and deaths. These stakeholders have called for evidence‐based guidance on th
Autor:
Marita Sporstøl Fønhus, Simon Lewin, Claire Glenton, Smisha Agarwal, Garrett Mehl, Nicholas Henschke, Hanna Bergman, Tigest Tamrat
Publikováno v:
Cochrane Database of Systematic Reviews
The Cochrane Database of Systematic Reviews
The Cochrane Database of Systematic Reviews
Background Health systems need timely and reliable access to essential medicines and health commodities, but problems with access are common in many settings. Mobile technologies offer potential low‐cost solutions to the challenge of drug distribut
Autor:
Marita Sporstøl Fønhus, Claire Glenton, Hanna Bergman, Gemma Villanueva, Nicholas Henschke, Garrett Mehl, Simon Lewin, Tigest Tamrat, Melissa J Palmer, Caroline Free, Nicola Maayan
Publikováno v:
The Cochrane Database of Systematic Reviews
Cochrane Database of Systematic Reviews
Cochrane Database of Systematic Reviews
Background The burden of poor sexual and reproductive health (SRH) worldwide is substantial, disproportionately affecting those living in low‐ and middle‐income countries. Targeted client communication (TCC) delivered via mobile devices (MD) (TCC
Autor:
Simon Lewin, Hanna Bergman, Gemma Villanueva, Garrett Mehl, Melissa J Palmer, Claire Glenton, Marita Sporstøl Fønhus, Nicholas Henschke, Nicola Maayan, Tigest Tamrat, Caroline Free
Publikováno v:
The Cochrane Database of Systematic Reviews
Cochrane Database of Systematic Reviews
Cochrane Database of Systematic Reviews
Background The global burden of poor maternal, neonatal, and child health (MNCH) accounts for more than a quarter of healthy years of life lost worldwide. Targeted client communication (TCC) via mobile devices (MD) (TCCMD) may be a useful strategy to
Autor:
Marita Sporstøl Fønhus, Bela Ganatra, Katherine C. Whitehouse, Ashley R. Brant, Antonella Lavelanet
Publikováno v:
Contraception: X, Vol 2, Iss, Pp 100037-(2020)
Contraception: X
Contraception: X
Background Mifepristone and misoprostol are recommended for second-trimester medical abortion, but consensus is unclear on the ideal regimen. Objectives The objectives were to systematically review randomized controlled trials (RCTs) investigating ef
Autor:
Garrett Mehl, Claire Glenton, Nicholas Henschke, Brian S Buckley, Ana Rita Maria, Gemma Villanueva, Daniela C Gonçalves-Bradley, Tigest Tamrat, Marita Sporstøl Fønhus, Sasha Shepperd, Ignacio Ricci-Cabello, Simon Lewin
Publikováno v:
Cochrane Database of Systematic Reviews
The Cochrane Database of Systematic Reviews
The Cochrane Database of Systematic Reviews
Background The widespread use of mobile technologies can potentially expand the use of telemedicine approaches to facilitate communication between healthcare providers, this might increase access to specialist advice and improve patient health outcom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ea2d98f0e7b96f78e0a02b3906bb341
https://hdl.handle.net/11250/3066747
https://hdl.handle.net/11250/3066747
Publikováno v:
International Journal of Gynecology & Obstetrics
Background Optimal dose, interval, and administration route of misoprostol with added benefit of mifepristone for management of second trimester intrauterine fetal death (IUFD) are not established. Objectives To assess effectiveness, safety, and acce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a934a97a04b904f1fcc241eaf99fbb24
http://hdl.handle.net/11250/2633176
http://hdl.handle.net/11250/2633176
Publikováno v:
Sykepleien Forskning. :e-87232
Publikováno v:
Sykepleien Forskning. :e-82899